JW (Cayman) Therapeutics Co Ltd
HKEX:2126
JW (Cayman) Therapeutics Co Ltd
Net Issuance of Debt
JW (Cayman) Therapeutics Co Ltd
Net Issuance of Debt Peer Comparison
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
|
Net Issuance of Debt
¥12.7m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Net Issuance of Debt
¥2.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
63%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Net Issuance of Debt
¥386.7m
|
CAGR 3-Years
5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Net Issuance of Debt
¥38m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Net Issuance of Debt
-¥3.4B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is JW (Cayman) Therapeutics Co Ltd's Net Issuance of Debt?
Net Issuance of Debt
12.7m
CNY
Based on the financial report for Dec 31, 2023, JW (Cayman) Therapeutics Co Ltd's Net Issuance of Debt amounts to 12.7m CNY.
What is JW (Cayman) Therapeutics Co Ltd's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
11%
Over the last year, the Net Issuance of Debt growth was -89%. The average annual Net Issuance of Debt growth rates for JW (Cayman) Therapeutics Co Ltd have been -30% over the past three years , 11% over the past five years .